Methylphenidate Side Effect Profile Is Influenced by Genetic Variation in the Attention-Deficit/Hyperactivity Disorder-Associated CES1 Gene

No Significant Association Between Genetic Variants in 7 Candidate Genes and Response to Methylphenidate Treatment in Adult Patients With ADHD

(2012) Verônica Contini et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate

(2012) E M Bruxel et al.   PHARMACOGENOMICS JOURNAL

A high density linkage disequilibrium mapping in 14 noradrenergic genes: evidence of association between SLC6A2, ADRA1B and ADHD

(2012) Ziarih Hawi et al.   PSYCHOPHARMACOLOGY

Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks

(2011) Amy F.T. Arnsten   BIOLOGICAL PSYCHIATRY

The impact of study design and diagnostic approach in a large multi-centre ADHD study: Part 2: Dimensional measures of psychopathology and intelligence

(2011) Ueli C Müller et al.   BMC Psychiatry

Clinically Relevant Doses of Methylphenidate Significantly Occupy Norepinephrine Transporters in Humans In Vivo

(2010) Jonas Hannestad et al.   BIOLOGICAL PSYCHIATRY

Pharmacogenetic Approach for a Better Drug Treatment in Children

(2010) Guilherme Polanczyk et al.   CURRENT PHARMACEUTICAL DESIGN

A Simple Allele-Specific Polymerase Chain Reaction Method to Detect the Gly143Glu Polymorphism in the Human Carboxylesterase 1 Gene: Importance of Genotyping for Pharmacogenetic Treatment

(2010) Néstor Walter Soria et al.   Genetic Testing and Molecular Biomarkers

Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: Potential sources of metabolic drug interactions

(2010) Hao-Jie Zhu et al.   TOXICOLOGY

Association Between Homozygosity of a G Allele of the Alpha-2a-Adrenergic Receptor Gene and Methylphenidate Response in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

(2009) Keun-Ah Cheon et al.   BIOLOGICAL PSYCHIATRY

Toward a New Understanding of Attention-Deficit Hyperactivity Disorder Pathophysiology

(2009) Amy F.T. Arnsten   CNS DRUGS

Age- and Sex-Related Expression and Activity of Carboxylesterase 1 and 2 in Mouse and Human Liver

(2009) H.-J. Zhu et al.   DRUG METABOLISM AND DISPOSITION

Dopamine-Related Genotypes and the Dose–Response Effect of Methylphenidate on Eating in Attention-Deficit/Hyperactivity Disorder Youths

(2009) John J. Leddy et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Dopamine Transporter Genotype and Stimulant Side Effect Factors in Youth Diagnosed with Attention-Deficit/Hyperactivity Disorder

(2009) Reut Gruber et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD

(2009) Zsofia Nemoda et al.   NEUROPHARMACOLOGY

A Haplotype of the Norepinephrine Transporter (Net) Gene Slc6a2 is Associated with Clinical Response to Atomoxetine in Attention-Deficit Hyperactivity Disorder (ADHD)

(2009) Nicolas Ramoz et al.   NEUROPSYCHOPHARMACOLOGY

Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis

(2008) Hao-Jie Zhu et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children

(2008) Eva Kereszturi et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Structural Organization and Characterization of the Regulatory Element of the Human Carboxylesterase (CES1A1 and CES1A2) genes

(2008) Masakiyo Hosokawa et al.   Drug Metabolism and Pharmacokinetics

Psychopharmacological and Other Treatments in Preschool Children with Attention-Deficit/Hyperactivity Disorder: Current Evidence and Practice

(2008) Jaswinder K. Ghuman et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY